Advanced Medical Solutions Appoints New Joint Corporate Broker

Advanced Medical Solutions ( (GB:AMS) ) just unveiled an announcement.

Advanced Medical Solutions Group plc has appointed Joh. Berenberg, Gossler & Co KG as a joint Corporate Broker alongside Investec Bank plc, effective immediately. This strategic move is expected to enhance AMS’s market presence and strengthen its financial advisory capabilities, potentially impacting its operations and industry positioning positively.

The most recent analyst rating on (GB:AMS) stock is a Buy with a £2.45 price target. To see the full list of analyst forecasts on Advanced Medical Solutions stock, see the GB:AMS Stock Forecast page.

Spark’s Take on GB:AMS Stock

According to Spark, TipRanks’ AI Analyst, GB:AMS is a Neutral.

The overall stock score is driven by strong financial performance with significant revenue growth and a solid capital structure. However, challenges such as declining profit margins and high valuation metrics impact the score negatively. Positive corporate events enhance the company’s outlook, but technical indicators suggest only a modest bullish trend.

To see Spark’s full report on GB:AMS stock, click here.

More about Advanced Medical Solutions

Advanced Medical Solutions Group plc (AMS) is a leading independent developer and manufacturer of innovative tissue-healing technologies, focusing on quality outcomes for patients and value for payers. The company offers a wide range of surgical products such as tissue adhesives, sutures, haemostats, internal fixation devices, and sealants under various brands. AMS also provides wound care dressings and has expanded its portfolio through several acquisitions since 2019. The company’s products are manufactured in multiple countries and sold globally through partners, distributors, and direct sales forces.

Average Trading Volume: 1,063,670

Technical Sentiment Signal: Sell

Current Market Cap: £424.1M

See more insights into AMS stock on TipRanks’ Stock Analysis page.